Trial Profile
Improvement of Ankle-Brachial Index by DLBS1033 Treatment in Diabetic Patients With Peripheral Arterial Disease
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Lumbricus rubellus (Primary)
- Indications Peripheral arterial disorders
- Focus Therapeutic Use
- Sponsors Dexa Medica
- 24 Jul 2018 Status changed from active, no longer recruiting to discontinued.
- 27 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 28 Jun 2017 Planned End Date changed from 1 Dec 2017 to 1 Sep 2018.